Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors

Clinical trial NCT00062127 · COMPLETED

Trial details

NCT number: NCT00062127
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2003-04-01
Primary completion: 2006-05-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.